Sempra reaffirms 7%-9% EPS growth target
Sempra reiterated its 7%-9% long-term EPS growth on the Q2 2026 call and outlined a SI Partners sale aimed at cutting about $9B of debt.

Sempra reaffirmed a long-term earnings-per-share growth target of 7% to 9% during its Q2 2026 earnings call, officials said. On the same call, the company outlined a plan to sell SI Partners, a transaction that officials said would reduce roughly $9 billion of debt.
The immediate response in equities was not clear following the update. Officials did not provide new numeric guidance for 2026 results as part of the Q2 2026 discussion.
Texas utilities positioned as the largest share of 2030 rate base Officials said Sempra is aiming for its Texas utilities to represent more than 60% of the company’s 2030 rate base. They pointed to growth catalysts at Oncor in describing why Texas is central to the company’s longer-term positioning.
Data referenced in the discussion indicated that the Texas emphasis is a key element of Sempra’s capital-allocation narrative and its projected earnings trajectory. The company’s framing ties the long-term EPS growth range to regulated earnings expansion through the decade.
SI Partners sale plan and the balance sheet focus Officials said proceeds from a sale of SI Partners would be directed toward debt reduction. If completed, they said, the debt paydown would lower leverage metrics and could improve credit flexibility.
Officials also described the transaction timing as a near-term point of focus for investors. Investors are expected to watch whether the SI Partners sale closes by December 31, 2026, because that timeline would shape the near-term effect on leverage and the company’s financing plans.
The company’s update also highlighted a set of risks that investors are likely to track as the strategy unfolds. Officials said the growing concentration in Texas makes state regulatory dynamics and construction execution areas of particular attention.
Officials said that if the SI Partners sale completes as planned, equity investors would see a shift in the balance sheet profile. They said that if the sale does not proceed as expected, leverage would remain higher and could weigh on valuation compared with peers.
More stories
- TG Therapeutics leads Valneva on 12 of 14 measures
- Pune police detain 92 over election-roll protest
- Tesla takes 90% of output from Arizona solar project
- New Horizon posts $4.1 million Q1 loss as R&D rises
- French Borrowing Costs Hit 5% as Debt Crisis Deepens
- Grabar probes shareholder claims at four Nasdaq companies
- GigaCloud shares watched after Aug. 6 Q2 2026 call
- Dell and NVIDIA Unveil Integrated Enterprise AI Infrastructure
- Big Tech AI Spending Pressures Investor Sentiment
- US Economic Growth Cools to 1.5% in Second Quarter
Latest news
- Putin relays Iran view to President Trump
- Red Cross says Gaza hostage access involved Haniyeh talks
- Trump urges Zelensky replacement over refinery strikes
- Saudi Arabia suspends Riyadh airport operations after attack
- Kyiv playground blast puts Ukraine air-defense stocks back on Washington’s agenda
- Rubio’s Athens speech hardens Washington’s public line on Iran
- Saudi airport hit in new Houthi attack, officials say

